Withdrawn from the Canadian market in July 1964 due to interactions with food products containing tyrosine.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Doxylamine | Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Iproniazid. |
| Dronabinol | Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Iproniazid. |
| Droperidol | Droperidol may increase the central nervous system depressant (CNS depressant) activities of Iproniazid. |
| Hydroxyzine | Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Iproniazid. |
| Magnesium sulfate | The therapeutic efficacy of Iproniazid can be increased when used in combination with Magnesium sulfate. |
| Methotrimeprazine | Iproniazid may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine. |
| Metyrosine | Iproniazid may increase the sedative activities of Metyrosine. |
| Minocycline | Minocycline may increase the central nervous system depressant (CNS depressant) activities of Iproniazid. |
| Nabilone | Nabilone may increase the central nervous system depressant (CNS depressant) activities of Iproniazid. |
| Orphenadrine | Iproniazid may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine. |
| Paraldehyde | Iproniazid may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde. |
| Perampanel | Perampanel may increase the central nervous system depressant (CNS depressant) activities of Iproniazid. |
| Pramipexole | Iproniazid may increase the sedative activities of Pramipexole. |
| Ropinirole | Iproniazid may increase the sedative activities of Ropinirole. |
| Rotigotine | Iproniazid may increase the sedative activities of Rotigotine. |
| Rufinamide | The risk or severity of adverse effects can be increased when Rufinamide is combined with Iproniazid. |
| Sodium oxybate | Iproniazid may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Suvorexant | Iproniazid may increase the central nervous system depressant (CNS depressant) activities of Suvorexant. |
| Thalidomide | Iproniazid may increase the central nervous system depressant (CNS depressant) activities of Thalidomide. |
| Zolpidem | Iproniazid may increase the central nervous system depressant (CNS depressant) activities of Zolpidem. |
| Desmopressin | The risk or severity of hypertension can be increased when Desmopressin is combined with Iproniazid. |
| Cyclosporine | The risk or severity of hypertension can be increased when Cyclosporine is combined with Iproniazid. |
| Icosapent | The risk or severity of hypertension can be increased when Icosapent is combined with Iproniazid. |
| Mesalazine | The risk or severity of hypertension can be increased when Mesalazine is combined with Iproniazid. |
| Methylergometrine | The risk or severity of hypertension can be increased when Methylergometrine is combined with Iproniazid. |
| Tolmetin | The risk or severity of hypertension can be increased when Tolmetin is combined with Iproniazid. |
| Fenoprofen | The risk or severity of hypertension can be increased when Fenoprofen is combined with Iproniazid. |
| Sulindac | The risk or severity of hypertension can be increased when Sulindac is combined with Iproniazid. |
| Sulfasalazine | The risk or severity of hypertension can be increased when Sulfasalazine is combined with Iproniazid. |
| Carprofen | The risk or severity of hypertension can be increased when Carprofen is combined with Iproniazid. |
| Phenmetrazine | The risk or severity of hypertension can be increased when Phenmetrazine is combined with Iproniazid. |
| Diflunisal | The risk or severity of hypertension can be increased when Diflunisal is combined with Iproniazid. |
| Meclofenamic acid | The risk or severity of hypertension can be increased when Meclofenamic acid is combined with Iproniazid. |
| Oxaprozin | The risk or severity of hypertension can be increased when Oxaprozin is combined with Iproniazid. |
| Balsalazide | The risk or severity of hypertension can be increased when Balsalazide is combined with Iproniazid. |
| Dutasteride | The risk or severity of hypertension can be increased when Dutasteride is combined with Iproniazid. |
| Finasteride | The risk or severity of hypertension can be increased when Finasteride is combined with Iproniazid. |
| Ephedrine | The risk or severity of hypertension can be increased when Ephedrine is combined with Iproniazid. |
| Magnesium salicylate | The risk or severity of hypertension can be increased when Magnesium salicylate is combined with Iproniazid. |
| Salsalate | The risk or severity of hypertension can be increased when Salsalate is combined with Iproniazid. |
| Choline magnesium trisalicylate | The risk or severity of hypertension can be increased when Choline magnesium trisalicylate is combined with Iproniazid. |
| Antrafenine | The risk or severity of hypertension can be increased when Antrafenine is combined with Iproniazid. |
| Tiaprofenic acid | The risk or severity of hypertension can be increased when Tiaprofenic acid is combined with Iproniazid. |
| Epicaptopril | The risk or severity of hypertension can be increased when Epicaptopril is combined with Iproniazid. |
| Taxifolin | The risk or severity of hypertension can be increased when Taxifolin is combined with Iproniazid. |
| Oxyphenbutazone | The risk or severity of hypertension can be increased when Oxyphenbutazone is combined with Iproniazid. |
| 1-benzylimidazole | The risk or severity of hypertension can be increased when 1-benzylimidazole is combined with Iproniazid. |
| Benoxaprofen | The risk or severity of hypertension can be increased when Benoxaprofen is combined with Iproniazid. |
| Metamizole | The risk or severity of hypertension can be increased when Metamizole is combined with Iproniazid. |
| Zomepirac | The risk or severity of hypertension can be increased when Iproniazid is combined with Zomepirac. |
| Cimicoxib | The risk or severity of hypertension can be increased when Iproniazid is combined with Cimicoxib. |
| Amibegron | The risk or severity of hypertension can be increased when Iproniazid is combined with Amibegron. |
| Nylidrin | The risk or severity of hypertension can be increased when Iproniazid is combined with Nylidrin. |
| Solabegron | The risk or severity of hypertension can be increased when Iproniazid is combined with Solabegron. |
| Saralasin | The risk or severity of hypertension can be increased when Iproniazid is combined with Saralasin. |
| Azapropazone | The risk or severity of hypertension can be increased when Iproniazid is combined with Azapropazone. |
| Salicylamide | The risk or severity of hypertension can be increased when Iproniazid is combined with Salicylamide. |
| Tyramine | The risk or severity of hypertension can be increased when Iproniazid is combined with Tyramine. |
| Adrafinil | The risk or severity of hypertension can be increased when Iproniazid is combined with Adrafinil. |
| Kebuzone | The risk or severity of hypertension can be increased when Iproniazid is combined with Kebuzone. |
| Isoxicam | The risk or severity of hypertension can be increased when Iproniazid is combined with Isoxicam. |
| Indoprofen | The risk or severity of hypertension can be increased when Iproniazid is combined with Indoprofen. |
| Ibuproxam | The risk or severity of hypertension can be increased when Iproniazid is combined with Ibuproxam. |
| Floctafenine | The risk or severity of hypertension can be increased when Iproniazid is combined with Floctafenine. |
| Fenbufen | The risk or severity of hypertension can be increased when Iproniazid is combined with Fenbufen. |
| Etofenamate | The risk or severity of hypertension can be increased when Iproniazid is combined with Etofenamate. |
| Etilefrine | The risk or severity of hypertension can be increased when Iproniazid is combined with Etilefrine. |
| Epirizole | The risk or severity of hypertension can be increased when Iproniazid is combined with Epirizole. |
| Benzydamine | The risk or severity of hypertension can be increased when Iproniazid is combined with Benzydamine. |
| Synephrine | The risk or severity of hypertension can be increased when Iproniazid is combined with Synephrine. |
| Moxisylyte | The risk or severity of hypertension can be increased when Iproniazid is combined with Moxisylyte. |
| Dexketoprofen | The risk or severity of hypertension can be increased when Iproniazid is combined with Dexketoprofen. |
| Droxicam | The risk or severity of hypertension can be increased when Iproniazid is combined with Droxicam. |
| Tolfenamic acid | The risk or severity of hypertension can be increased when Iproniazid is combined with Tolfenamic acid. |
| Firocoxib | The risk or severity of hypertension can be increased when Iproniazid is combined with Firocoxib. |
| Clonixin | The risk or severity of hypertension can be increased when Iproniazid is combined with Clonixin. |
| Morniflumate | The risk or severity of hypertension can be increased when Iproniazid is combined with Morniflumate. |
| Talniflumate | The risk or severity of hypertension can be increased when Iproniazid is combined with Talniflumate. |
| Dihydroergocornine | The risk or severity of hypertension can be increased when Iproniazid is combined with Dihydroergocornine. |
| DL-Methylephedrine | The risk or severity of hypertension can be increased when Iproniazid is combined with DL-Methylephedrine. |
| Amitraz | The risk or severity of hypertension can be increased when Iproniazid is combined with Amitraz. |
| Robenacoxib | The risk or severity of hypertension can be increased when Iproniazid is combined with Robenacoxib. |
| Tepoxalin | The risk or severity of hypertension can be increased when Iproniazid is combined with Tepoxalin. |
| Atipamezole | The risk or severity of hypertension can be increased when Iproniazid is combined with Atipamezole. |
| Flunixin | The risk or severity of hypertension can be increased when Iproniazid is combined with Flunixin. |
| Ractopamine | The risk or severity of hypertension can be increased when Iproniazid is combined with Ractopamine. |
| Tulobuterol | The risk or severity of hypertension can be increased when Iproniazid is combined with Tulobuterol. |
| Dopexamine | The risk or severity of hypertension can be increased when Iproniazid is combined with Dopexamine. |
| Idazoxan | The risk or severity of hypertension can be increased when Iproniazid is combined with Idazoxan. |
| Ebselen | The risk or severity of hypertension can be increased when Iproniazid is combined with Ebselen. |
| Higenamine | The risk or severity of hypertension can be increased when Iproniazid is combined with Higenamine. |
| Reproterol | The risk or severity of hypertension can be increased when Iproniazid is combined with Reproterol. |
| Theodrenaline | The risk or severity of hypertension can be increased when Iproniazid is combined with Theodrenaline. |
| Tinoridine | The risk or severity of hypertension can be increased when Iproniazid is combined with Tinoridine. |
| Tramazoline | The risk or severity of hypertension can be increased when Iproniazid is combined with Tramazoline. |
| Alclofenac | The risk or severity of hypertension can be increased when Iproniazid is combined with Alclofenac. |
| Fentiazac | The risk or severity of hypertension can be increased when Iproniazid is combined with Fentiazac. |
| Suxibuzone | The risk or severity of hypertension can be increased when Iproniazid is combined with Suxibuzone. |
| Octopamine | The risk or severity of hypertension can be increased when Iproniazid is combined with Octopamine. |
| Bumadizone | The risk or severity of hypertension can be increased when Iproniazid is combined with Bumadizone. |